查詢結果分析
相關文獻
- Power BI視覺化儀表板於醫院抗生素管理計畫之應用
- 資料視覺化構建工程藍圖
- Nosocomial Acinetobacter baumannii Bacteremia: Comparison of the Clinical Manifestations of Multiresistant Strain and Non-multiresistant Strain Infections
- 全矩陣式資料視覺化與資訊探索
- 黑殭菌抗殺菌劑菌株之篩選
- 應用切片逆迴歸法於區間型符號資料之維度縮減
- 多重抗藥性菌株資訊自動化監測與應用
- 探討抗生素管理計畫對醫療機構與照護品質所產生之影響
- 抗生素管理計畫之重要性
- 微陣列資訊識別與視覺化處理
頁籤選單縮合
| 題 名 | Power BI視覺化儀表板於醫院抗生素管理計畫之應用=Utilizing Microsoft Power BI Dashboards to Visualize Antibiotic Use in Hospital Antibiotic Stewardship Programs |
|---|---|
| 作 者 | 林佳諭; 郭欣慧; 鄭雅庭; 張詠婕; 黃微瑄; 張秀美; 陳惇杰; | 書刊名 | 感染控制雜誌 |
| 卷 期 | 34:5 2024.10[民113.10] |
| 頁 次 | 頁297-312 |
| 分類號 | 418.281 |
| 關鍵詞 | 資料視覺化; Power BI儀表板; 抗生素管理計畫; 抗藥性菌株; Data visualization; Power BI dashboard; Antimicrobial stewardship program; Antibiotic-resistant bacteria; |
| 語 文 | 中文(Chinese) |
| DOI | 10.6526/ICJ.202410_34(5).0002 |
| 中文摘要 | 「監測抗微生物製劑使用」是醫療院所進行抗生素管理計畫中重要的一環。 商業智慧 (business intelligence, BI) 具備資料整合、資料視覺化、即時互動等特 色,目前已有醫療領域導入運用並頗具成效。本研究描述 Power BI 儀表板的建 置過程,並探討導入視覺化儀表板於醫院抗生素管理計畫之應用成果。收集 2021 年 1 月至 2023 年 12 月院內抗生素耗用量、門急診就診人次、住院人日數、抗生 素處方明細、感染科醫師抗生素審核資料,以及特定抗藥性菌株數量。Power BI 儀表板使用多種視覺化功能,以敘述性統計進行資料分析。研究期間建置 5 種儀 表板:(1) 門急診與住院抗生素耗用密度;(2) 單一抗生素使用情形;(3) 抗生素耗 用密度管制圖趨勢;(4) 抗藥性菌株與特定抗生素耗用密度分析;(5) 感染科醫師 第二線管制性抗生素審核率分析。透過儀表板監測應用成果如下:(1) 即時發現 2021 年第三季骨科門診口服 levofloxacin 耗用密度增加至 29.7,專科醫師介入評 估後同年第四季耗用密度下降至 10.2。(2) 2023 年 5 月引進困難梭狀桿菌毒素聚 合連鎖檢測,同年第三季口服 vancomycin 處方量有下降趨勢。(3) 感染科醫師管 制性抗生素審核率每季皆達標且維持 70% 以上。Power BI 視覺化儀表板可即時 分析使用趨勢及異常用量,有效提昇抗生素使用及感染控制相關管理品質。 |
| 英文摘要 | Tracking antibiotic use is a crucial element in hospital antibiotic stewardship programs. Considering that Microsoft Power BI offers customized dashboards for effective data visualization, we aimed to assess the effectiveness of these dashboards in combination with other interventions in antibiotic stewardship programs. Data on antibiotic prescriptions, daily hospital visits, and multidrug-resistant bacterial counts were collected between January 2021 and December 2023. The dashboards implemented various types of visualizations, including bar and column charts, single numbers, combo charts, doughnut charts, line charts, matrix displays, pie charts, slicers, and tables. Descriptive statistics were used for the data analysis. In this study, we identified five types of dashboards for antibiotic use: (a) outpatient, inpatient, and emergency department defined daily dose per 1,000 inhabitants per day (DID); (b) antibiotic prescription data, such as glycopeptides; (c) control charts for carbapenems, fluoroquinolones, and glycopeptides; (d) combo charts presenting multidrug-resistant bacterial counts and DID consumption for carbapenems and glycopeptides; and (e) audit rates and approval status of reserve antibiotics by infectious disease specialists. The dashboards provided several valuable insights. First, a significant increase in levofloxacin oral tablet DID in orthopedics was observed during the third quarter of 2021. Effective audits resulted in a subsequent decline in DID in the following quarter. Second, an increasing trend was observed in the treatment of Clostridium difficile infections since 2022. However, orally administered vancomycin was occasionally prescribed by doctors due to positive GDH antigen and negative toxin A/B results, without PCR test results. Therefore, introducing the PCR test in May 2023 may improve the diagnosis of Clostridium difficile-associated diarrhea (CDAD). Finally, the audit rates of reserve antibiotics have consistently exceeded 70% every quarter since 2022. In summary, power BI dashboards offer a valuable tool for hospitals to understand antibiotic usage trends and identify anomalies. The dashboards assist hospital management in formulating strategies and improving various aspects of quality management. |
本系統中英文摘要資訊取自各篇刊載內容。